gam-covid-vac (rad5)
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 5, 2021 (NCT04954092)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
immunity, active - SARS-CoV-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05027672 | Phase 2 | Jul 30, 2021 | Government of Argentina |
| NCT04954092 | Phase 2/Phase 3 (Phase 3) | Jul 5, 2021 | Government of Russia, Moscow City Health Department, Moscow Healthcare Department |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Argentina | Government | 1 | 1 | 1 | 2021 |
| Government of Russia | Government | 1 | 1 | 1 | 2021 |
| Moscow City Health Department | Government | 1 | 0 | 1 | 2021 |
| Moscow Healthcare Department | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1